Newron Pharmaceuticals S.p.A.

SIX:NWRN.SW

7.71 (CHF) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22011 Q42011 Q22010 Q42010 Q22009 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 6.3387.71313.42418.88325.01911.42913.21321.85722.05212.24127.62331.26840.64240.43142.94830.45736.01138.52518.75622.26618.42621.76629.24315.4555.36710.1678.08713.14422.689
Short Term Investments 6.2619.4269.359.4759.57510.47718.03717.50817.11117.16716.2319.36819.4394.6373.524.4224.925.4756.9469.1245.4573.6083.641000001.605
Cash and Short Term Investments 12.59917.13922.77428.35834.59421.90631.2539.36539.16329.40843.85350.63660.08145.06846.46834.87940.9314425.70231.3918.42621.76629.24315.4555.36710.1678.08713.14424.294
Net Receivables 2.0222.0261.9441.7031.3081.6826.6241.3811.7491.5451.2422.1591.0662.0731.3291.1121.2191.6832.712.1815.4573.6083.641000000
Inventory 000000000000.0050.0050.0050.0050.0380.0380.0980.1020.1980.3010.2280.2330.2270.2460.3950.3960.4660.38
Other Current Assets 5.0315.0763.7753.7493.5254.28502.8174.57928.46214.41712.05211.6489.6928.3382.2381.7862.20.8741.053-2.387-0.417-0.376.1232.0162.4584.6235.3247.064
Total Current Assets 19.65224.24128.49333.8139.42727.87337.87443.56345.49159.41559.51264.85272.856.83856.1438.26743.97447.98129.38834.82221.79725.18532.74721.8057.62913.0213.10618.93431.738
Non-Current Assets:
Property, Plant & Equipment, Net 0.4050.4720.5270.6170.5770.6470.7340.7820.2520.3190.3740.1070.1070.1150.120.1180.0790.0670.0670.0670.0790.0770.0720.0360.0560.0930.1280.1860.241
Goodwill 00000000000000000000000000000
Intangible Assets 0000.0010.0020.0060.0110.0160.020.0250.030.0340.0350.2920.2610.2640.2656.9916.9939.129.12511.21211.1995.1655.1715.1785.1888.9698.979
Goodwill and Intangible Assets 0000.0010.0020.0060.0110.0160.020.0250.030.0340.0350.2920.2610.2640.2656.9916.9939.129.12511.21211.1995.1655.1715.1785.1888.9698.979
Long Term Investments 000000000000000000.5840.5840.584-4.873-3.024-3.05700000-1.021
Tax Assets 00000000000000000000000000000
Other Non-Current Assets 5.809-0.472-0.527-0.618-0.579-0.653-0.745-0.798-0.272-0.344-0.404-0.141-0.142-0.407-0.381-0.382-0.344-7.642-7.644-9.7715.493.6523.6860.8570.710.7180.710.7351.741
Total Non-Current Assets 6.2140.4720.5270.6180.5790.6530.7450.7980.2720.3440.4040.1410.1420.4070.3810.3820.3447.6427.6449.7719.82111.91711.96.0585.9375.9896.0269.899.94
Total Assets 25.86631.49437.19543.54350.48639.88651.19857.83460.28859.83959.99965.07673.02457.32956.59138.71444.3855.6737.07444.62631.61837.10244.64727.86313.56619.00919.13228.82441.678
Liabilities & Equity:
Current Liabilities:
Account Payables 2.0191.8791.9090.6891.5031.2391.2731.7042.4061.7131.1491.2582.2234.5141.9835.541.6364.9191.0464.3111.3163.931.881000000
Short Term Debt 22.45212.580.1720.1730.150.1570.1510.1350.060.1380000.1820.3640.3630.3620.3580.3580.3590.3580.3560.3550.3550.3550.17700.2810.281
Tax Payables 00000000000000000000000000000
Deferred Revenue 0-12.58-0.172-0.173-0.15-0.157-0.151-0.135-0.06-0.138000-0.182-0.364-0.363-0.362-0.358-0.358-0.359000000000
Other Current Liabilities 4.45514.8833.1323.1372.1512.2915.6192.9373.1895.4583.2832.2272.5040.1824.6620.3634.8770.5153.4431.6784.3962.0919.3499.6682.4722.7924.6357.7948.374
Total Current Liabilities 28.92616.7625.0413.8263.6543.536.8924.6415.5957.1714.4323.4854.7274.6966.6455.9036.5135.4344.4895.9896.076.37711.58510.0232.8272.9694.6358.0758.655
Non-Current Liabilities:
Long Term Debt 25.96334.21845.16543.88642.54226.37425.67424.70216.7499.3480.12500000.1820.3640.5490.7290.9071.0871.2671.4471.6251.8021.980-2.779-2.658
Deferred Revenue Non-Current 0000000000000000.1070.289-1.719-1.539-1.9980000.915-3.1650.06400.2020.081
Deferred Tax Liabilities Non-Current 00000000000000.0750.0750.0750.0752.2682.2682.9052.9053.5313.5311.7181.7181.7181.7182.8582.858
Other Non-Current Liabilities 0.885-34.218-45.165-43.886-42.542-26.374-25.674-24.702-16.749-9.3480.481000.0690.124-0.182-0.364-0.549-0.729-0.9070.4660.4440.4760.6233.7990.6010.5883.3693.459
Total Non-Current Liabilities 26.84834.21845.16543.88642.54226.37425.67424.70216.7499.3480.6060.6010.5760.1440.1990.1820.3640.5490.7290.9074.4585.2425.4544.8814.1544.3632.3063.653.74
Total Liabilities 55.77452.45651.22548.78847.37931.19433.95230.71723.4917.8525.1634.0865.3034.846.8446.3367.2688.5627.81310.22110.52811.61917.03914.9046.9817.3326.94111.72512.395
Equity:
Preferred Stock 12.08112.294000000000000000000000000000
Common Stock 3.5693.5693.5693.5693.5693.5693.5693.5693.5693.5693.5693.5693.5673.1633.1552.892.8442.82.6092.6092.3252.3252.2771.5981.4531.4531.4531.3211.312
Retained Earnings -21.396-12.237-22.805-13.933-20.116-14.235-26.157-15.74-25.341-19.165-20.203-12.757-10.464-2.868-19.782-13.405-31.914-16.01-16.98-11.473-12.313-7.643-7.549-2.473-11.795-6.188-29.074-21.454-27.422
Accumulated Other Comprehensive Income/Loss -12.081-12.2945.2065.11914.55314.25713.73513.18912.26411.27710.1298.8488.0797.4466.8565.5744.6023.4032.7292.369-2.51.868-3.040-1.903000-1.713
Other Total Stockholders Equity -12.081-12.294005.1015.10126.09926.09946.30646.30661.34161.3366.53944.74859.51837.31961.5856.91540.90340.933.57828.93335.9213.83418.8316.41239.81237.23257.106
Total Shareholders Equity -29.908-20.962-14.03-5.2453.1078.69217.24627.11736.79841.98754.83660.9967.72152.48949.74732.37837.11247.10829.26134.40521.0925.48327.60812.9596.58511.67712.19117.09929.283
Total Equity -29.908-20.962-14.03-5.2453.1078.69217.24627.11736.79841.98754.83660.9967.72152.48949.74732.37837.11247.10829.26134.40521.0925.48327.60812.9596.58511.67712.19117.09929.283
Total Liabilities & Shareholders Equity 25.86631.49437.19543.54350.48639.88651.19857.83460.28859.83959.73165.07673.02457.32956.59138.71444.3855.6737.07444.62631.61837.10244.64727.86313.56619.00919.13228.82441.678